The latest trading session saw Medtronic (MDT) ending at $87.72, denoting a -0.45% adjustment from its last day's close. The stock's change was less than the S&P 500's daily gain of 0.38%. Meanwhile, ...

Ping An Healthcare and Technology Company Limited established a strategic partnership with Medtronic (MDT) Management Co., Ltd. at the 7th ...

Medtronic plc MDT is scheduled to report second-quarter fiscal 2025 results on Nov. 19, before the opening bell. In the last reported quarter, the company’s adjusted earnings of $1.23 exceeded the ...

A replay of the webcast will be available on the Events section of the Orchestra BioMed website for 90 days following the presentation.

The rapidly growing aging population is driving expansion in healthcare, with rising demand for treatments and chronic disease management. Companies like AbbVie (ABBV), Medtronic (MDT), and Centene ...

Medtronic unveils outcomes of the largest multi-centric prospective stroke registry on mechanical thrombectomy in India (PRAAN) ...

A new medical technology fund which focusses on early-stage health technologies is itself an innovation. Utilizing its ...

About a year ago, renal denervation procedures won a huge victory after finally being greenlit by FDA. Now two of the frontrunners in the space have received reimbursement.

Princeton-based Integra LifeSciences has appointed Mojdeh Poul as the new president and chief executive officer, effective ...

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal ...

Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation ...